Status:
TERMINATED
Nextsense Brain-sensing Buds Study
Lead Sponsor:
NextSense, Inc.
Conditions:
Sleep
Sleep Quality
Eligibility:
All Genders
25-65 years
Phase:
NA
Brief Summary
The purpose of this clinical trial is to explore how the presentation of sleep data impacts sleep quality, sleep-related behaviors (such as sleepiness), and sleep-related anxiety and stress. The study...
Detailed Description
With the growing prevalence of sleep-tracking wearables available to consumers, understanding the psychological and behavioral impacts they have on users is important. Recent advancements in wearable ...
Eligibility Criteria
Inclusion
- All participants have the capacity to understand the informed consent for study participation and ability for subject to comply with the requirements of the study
- Experiencing mild to moderate sleep disturbances, but without sleep disorder diagnosis
- Naïve to sleep tracker use
- Age 25-65
Exclusion
- Participants who have used any type of sleep tracker, such as Oura, Fitbit, Google Fit, Garmin Connect, or Apple Watch Sleep
- Health conditions (i.e., cancer, cognitive impairment, panic disorder, post-traumatic stress disorder, sleep apnea, insomnia, restless leg syndrome, Parkinson's disease)
- Use of Modafinil (Provigil), Methylphenidate (Ritalin), Sodium oxybate (Xyrem), Melatonin, Benadryl, Wakix, Sunosi or prescription medications for ADHD Enrollment in other sleep studies
- Women who are pregnant or who are currently nursing/breastfeeding will be excluded from this study.
Key Trial Info
Start Date :
October 7 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 15 2025
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT06602960
Start Date
October 7 2024
End Date
April 15 2025
Last Update
April 18 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Alethios (Virtual Study Platform)
San Francisco, California, United States, 94109